Day Pitney LLP is a full-service law firm with more than 300 attorneys in Boston, Connecticut, Florida, New Jersey, New York and Washington, DC. The firm offers clients strong corporate and litigation practices, with experience on behalf of large national and international corporations as well as emerging and middle-market companies. With one of the largest individual clients practices on the East Coast, the firm also has extensive experience assisting individuals and their families, fiduciaries and tax-exempt entities plan for the future.
A preclinical study performed by scientists at the University of North Carolina and Duke University has demonstrated the potential for the treatment of ovarian cancer using nanotechnology.
United StatesFood, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.
Originally published in The Nano Newswire
A preclinical study performed by scientists at the
University of North Carolina and Duke University has demonstrated
the potential for the treatment of ovarian cancer using
nanotechnology.
The team used nanoparticle technology to specifically target
metastasized ovarian cancer cells and to deliver a chemotherapy
drug and a radiotherapy isotope directly to the cancerous cells. In
addition to eradicating the cancer, this method was found to lessen
the toxicity often associated with traditional treatments. The
researchers hope that the targeted nature of these nanopartical
therapeutic carriers will aid in the treatment of peritoneal
metastasis to the lining of the abdomen, which is a major cause of
ovarian cancer deaths.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
